An investment in the Notes involves risks. You should carefully consider the risks and uncertainties described in this prospectus supplement and the accompanying prospectus, including the risk factors set forth in the documents and reports filed with the SEC that are incorporated by reference in this prospectus supplement and in the accompanying prospectus, such as the risk factors under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023, which is incorporated by reference herein and is on file with the SEC, before you make an investment decision pursuant to this prospectus supplement and the accompanying prospectus. Our business, financial condition, operating results and cash flows can be impacted by the factors set forth below and in such documents and reports. In this “Risk Factors” section, when we refer to “Otis,” “we,” “our,” or “us,” we refer to Otis Worldwide Corporation and any successor obligor and not to any of its subsidiaries.
Risks Related to the Notes
In addition to the indebtedness that will be issued in this offering, we have significant outstanding indebtedness including outstanding notes, commercial paper, and significant unused borrowing capacity under our Revolving Credit Facility (as defined below). We may incur additional debt in the future. The terms of the Revolving Credit Facility, the Indenture and the Highland Indenture (as defined below), and the terms of any future indebtedness, may restrict the activities of Otis and its subsidiaries.
We have outstanding debt and other financial obligations and significant unused borrowing capacity under our Revolving Credit Facility. Our debt may increase as a result of this offering. See “Capitalization.”
As of September 30, 2024, Otis and its subsidiaries had approximately $7.26 billion of outstanding indebtedness, including short-term borrowings, consisting of (i) $5.55 billion principal amount of U.S. dollar denominated unsecured, unsubordinated long-term notes in six series with maturity dates ranging from 2025 to 2050 issued pursuant to the Indenture, dated as of February 27, 2020, between Otis and The Bank of New York Mellon Trust Company, N.A. (as amended or supplemented from time to time, the “Indenture”), (ii) ¥21.5 billion principal amount of Japanese Yen denominated (approximately $149 million as of September 30, 2024), unsecured, unsubordinated five-year notes due March 2026 issued pursuant to the Indenture, (iii) €1.1 billion principal amount of Euro denominated (approximately $1.2 billion as of September 30, 2024), unsecured, unsubordinated notes issued pursuant to the Indenture, dated as of November 12, 2021, among Highland Holdings S.à r.l., as issuer, Otis, as guarantor, and The Bank of New York Mellon Trust Company, N.A. (as amended or supplemented from time to time, the “Highland Indenture”), and (iv) $316 million in borrowings outstanding under Otis’ and its subsidiaries’ $1.5 billion unsecured, unsubordinated commercial paper programs. As of September 30, 2024, there were no borrowings outstanding under the credit agreement providing for a $1.5 billion unsecured, unsubordinated five-year revolving credit facility (as amended or supplemented from time to time, the “Revolving Credit Facility”).
The Revolving Credit Facility, the Indenture and the Highland Indenture impose restrictions on Otis and certain subsidiaries, including certain restrictions customary for financings of these types that, among other things, limit the ability to incur additional liens, to make certain fundamental changes and to enter into sale and leaseback transactions. In addition, the Revolving Credit Facility requires Otis to comply with a maximum consolidated total net debt to EBITDA leverage ratio. The Revolving Credit Facility, the Indenture and the Highland Indenture contain events of default customary for financings of these types.
The ability of Otis and its subsidiaries, as applicable, to comply with such restrictions and covenants may be affected by events beyond their control. If Otis or its subsidiaries, as applicable, breaches any of these restrictions or covenants and does not obtain a waiver from the lenders or holders, as applicable, then, subject to the applicable cure periods and conditions, any outstanding indebtedness under the Revolving Credit Facility, the Indenture or the Highland Indenture, as applicable, could be declared immediately due and payable. Otis and its subsidiaries may incur significantly more indebtedness in the future by drawing under the Revolving Credit Facility or otherwise. The Indenture does not limit our and our subsidiaries’ indebtedness, prevent dividends or generally prevent highly leveraged transactions, and there are no financial covenants in the Indenture. As a result, we may incur additional debt, which could increase the risks associated with our substantial debt.
Neither Otis nor any of Otis’ subsidiaries is restricted from incurring additional unsecured debt or other liabilities, including additional unsubordinated debt, under the Indenture. If we incur additional debt or liabilities, Otis’ ability to pay its obligations on the Notes could be adversely affected. We expect that we will from time to